Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470723) titled 'The ORIGIN-FH Study' on March 9.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: University of Wisconsin, Madison
Condition:
Heterozygous Familial Hypercholesterolemia (HeFH)
Homozygous Familial Hypercholesterolemia (HoFH)
Familial Hypercholesterolemia
Intervention:
Diagnostic Test: Screening for FH
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: February 14, 2026
Target Sample Size: 70
Countries of Recruitment:
United States
To know more, visit https://...